Pioneering Breakthrough Nerve Mapping and Ablation with the World’s First GPS for the Nervous System
Autonomix is pioneering a new frontier in neural signal detection with breakthrough technology that, for the first time ever, seeks to enable the sensing of nerve activity from within the body’s vasculature creating what could become the world’s first GPS for the nervous system.
This revolutionary capability lays the foundation for a powerful platform that could transform how neurological conditions are diagnosed and treated by precisely identifying and targeting overactive individual nerves.
Unparalleled Sensitivity. Unmatched Precision.
Autonomix’s state-of-the-art custom-designed sensing antennae array has achieved detection thresholds below 5 µV, using prototype electrodes as small as 0.02 mm x 0.03 mm.
This enables the capture of both high-fidelity signal resolution and spatial precision setting a new benchmark for the industry. This leap in sensitivity opens the door to a transformative method of transvascular nerve targeting, treatment, and confirmation: a novel approach that could address a wide spectrum of conditions.
Lab-Grade Processing, Miniaturized.
Today’s nerve-sensing technologies rely on sending faint electrical signals through wires to external, room-sized processors, an approach that often loses critical data along the way.
Autonomix disrupts this model by compressing an entire lab into a 1×2 mm microchip with embedded sensing and processing electronics. Positioned just millimeters from the targeted nerve, our system enables unprecedented sensitivity, empowering physicians to precisely locate and ablate overactive nerves with confidence.
Processing Power Brought Directly to the Nerves.
What sets Autonomix apart is our globally patent protected combination of ultra-sensitive nerve detection and a proprietary microchip that processes signals directly at the point of detection.
By embedding this advanced microchip technology within millimeters of the target nerve, localized processing minimizes signal degradation and preserves fidelity to enable real-time, high-resolution signal capture from within the vascular system. No other platform today offers this capability.

